Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor TreatmentRosaria Chilà, Giovanna Damia|Frontiers in Oncology|2022Cited by 8